Global Antibiotic Research and Development Partnership
room 15 Chemin Camille-Vidart | 1202 Geneva | Switzerland
arrow_back See all Activities

Serious Bacterial Infections

IATI Identifier:

Published on IATI
  • date_range Jan 01, 2020
  • autorenew Implementation (Status)

Serious bacterial infections are a major cause of death in hospitals and healthcare settings. Bacteria can enter the body through wounds and surgery sites, ventilators and catheters, leading to pneumonia, urinary tract, abdominal and bloodstream infections. The Global Antibiotic Research and Development Partnership (GARDP) is working to develop new treatments for these serious bacterial infections, focusing on treatments for drug-resistant bacteria on the World Health Organization’s (WHO) priority pathogens list.

more_horiz
Sectors:

  • Medical research

Participating Organisations

Global Antibiotic Research and Development Partnership Public Private Partnership Implementing
German Federal Ministry of Education and Research Government Funding
Japanese Ministry of Health, Labour & Welfare Government Funding
UK - Department of Health and Social Care (DHSC) Government Funding

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

0 USD
access_time Updated on Oct 29, 2021 08:11:35